Well-being and relationship satisfaction of couples dealing with an in vitro fertilization/ intracytoplasmic sperm injection procedure: a multilevel approach on the role of self-criticism, dependency, and romantic attachment
Objective
To extend existing research on the psychological impact of IVF by studying the association between the psychosocial factors of self-criticism and dependency, and romantic attachment, with the well-being and relationship satisfaction of couples across the different phases of IVF/intracytoplasmic sperm injection (ICSI) treatment.
Design
Prospective, three-wave study (i.e., from start of IVF/ICSI treatment, to 3- and 6-month follow-up).
Setting
University hospital.
Patient(s)
Seventy couples in IVF/ICSI treatment.
Intervention(s)
Psychometric tests were administered at first visit of IVF/ICSI treatment, and at 3- and 6-month follow-up.
Main Outcome Measure(s)
Psychological well-being, relationship satisfaction.
Result(s)
Results demonstrated that preexisting psychosocial factors such as self-criticism, dependency, and romantic attachment are more important factors for psychological well-being and relationship satisfaction during IVF/ICSI than gender and treatment-related factors such as duration of fertility problems. In addition, multilevel analysis, a statistical method that is required for the analysis of longitudinal couple data and decomposes variation in three levels (i.e., time, individuals, and couples), showed more variation in psychological well-being and relationship satisfaction between couples, than between individuals and different time measurements.
Conclusion(s)
Preexisting personality factors and being embedded within a certain couple relationship are important factors for the psychological well-being and relationship satisfaction during IVF/ICSI.
Key Words: IVF, couples, well-being, relationship satisfaction, romantic attachment, self-criticism, dependency
To access this article, please choose from the options below
B.L. has nothing to disclose. P.L. has nothing to disclose. J.C. has nothing to disclose. T.D. has received research funding from Merck-Serono, Pfizer, Ferring, and Organon. E.B. has nothing to disclose. K.D. has received honoraria from Boehringer Ingleheim, Eli Lilly, Lundbeck, and Wyeth.
PII: S0015-0282(07)04114-3
doi:10.1016/j.fertnstert.2007.11.052
© 2009 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

